A detailed history of De Dora Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, De Dora Capital, Inc. holds 5,436 shares of AMGN stock, worth $1.74 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
5,436
Previous 5,360 1.42%
Holding current value
$1.74 Million
Previous $1.67 Million 4.6%
% of portfolio
0.51%
Previous 0.52%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$309.38 - $337.38 $23,512 - $25,640
76 Added 1.42%
5,436 $1.75 Million
Q2 2024

Jul 17, 2024

BUY
$262.75 - $319.31 $13,663 - $16,604
52 Added 0.98%
5,360 $1.67 Million
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $257,846 - $311,253
959 Added 22.05%
5,308 $1.51 Million
Q4 2023

Jan 18, 2024

SELL
$255.7 - $288.46 $8,182 - $9,230
-32 Reduced 0.73%
4,349 $1.25 Million
Q3 2023

Oct 18, 2023

SELL
$218.65 - $271.46 $24,270 - $30,132
-111 Reduced 2.47%
4,381 $1.18 Million
Q2 2023

Jul 24, 2023

SELL
$214.27 - $253.37 $55,495 - $65,622
-259 Reduced 5.45%
4,492 $997,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $5,418 - $6,604
24 Added 0.51%
4,751 $1.15 Million
Q4 2022

Jan 18, 2023

BUY
$229.03 - $291.01 $12,825 - $16,296
56 Added 1.2%
4,727 $0
Q3 2022

Oct 14, 2022

BUY
$224.46 - $253.15 $36,811 - $41,516
164 Added 3.64%
4,671 $1.05 Million
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $115,355 - $128,370
-500 Reduced 9.99%
4,507 $1.1 Million
Q1 2022

Apr 14, 2022

BUY
$219.27 - $242.57 $1.1 Million - $1.21 Million
5,007 New
5,007 $1.21 Million
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $951,243 - $1.09 Million
-4,783 Closed
0 $0
Q3 2021

Oct 18, 2021

BUY
$212.27 - $248.7 $17,830 - $20,890
84 Added 1.79%
4,783 $1.02 Million
Q2 2021

Aug 03, 2021

SELL
$233.58 - $259.14 $52,789 - $58,565
-226 Reduced 4.59%
4,699 $1.15 Million
Q1 2021

Apr 27, 2021

SELL
$221.91 - $258.6 $20,637 - $24,049
-93 Reduced 1.85%
4,925 $1.23 Million
Q4 2020

Jan 29, 2021

SELL
$216.38 - $257.67 $81,358 - $96,883
-376 Reduced 6.97%
5,018 $1.15 Million
Q3 2020

Oct 20, 2020

BUY
$234.65 - $260.95 $8,916 - $9,916
38 Added 0.71%
5,394 $1.37 Million
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $106,223 - $130,351
-537 Reduced 9.11%
5,356 $1.26 Million
Q1 2020

May 04, 2020

BUY
$182.24 - $241.7 $6,378 - $8,459
35 Added 0.6%
5,893 $1.2 Million
Q4 2019

Feb 21, 2020

SELL
$189.21 - $243.2 $22,705 - $29,184
-120 Reduced 2.01%
5,858 $1.41 Million
Q3 2019

Oct 22, 2019

BUY
$174.11 - $208.62 $48,750 - $58,413
280 Added 4.91%
5,978 $1.16 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $38,841 - $45,530
-233 Reduced 3.93%
5,698 $1.05 Million
Q1 2019

Apr 12, 2019

BUY
$180.87 - $203.88 $53,356 - $60,144
295 Added 5.23%
5,931 $1.13 Million
Q4 2018

Jan 18, 2019

BUY
$178.4 - $208.25 $74,392 - $86,840
417 Added 7.99%
5,636 $1.1 Million
Q3 2018

Oct 19, 2018

SELL
$185.29 - $208.89 $370 - $417
-2 Reduced 0.04%
5,219 $1.08 Million
Q2 2018

Jul 31, 2018

SELL
$166.05 - $186.51 $375,937 - $422,258
-2,264 Reduced 30.25%
5,221 $964,000
Q1 2018

Apr 16, 2018

BUY
$169.43 - $198.0 $112,670 - $131,670
665 Added 9.75%
7,485 $1.28 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $1.15 Million - $1.29 Million
6,820
6,820 $1.19 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track De Dora Capital, Inc. Portfolio

Follow De Dora Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of De Dora Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on De Dora Capital, Inc. with notifications on news.